MedPath

Efficacy of freeze-dried platelet-rich plasma (FD-PRP) in bone engineering: Pilot study

Not Applicable
Conditions
alveolar bone atrophy
Registration Number
JPRN-UMIN000027144
Lead Sponsor
Department of Regenerative Oral Surgely, Nagasaki University Graduate School of Biomediacal Sciences
Brief Summary

The purpose of this study is to evaluate the safety and preliminary efficacy of autologous freeze-drying platelet-rich plasma (FD-PRP) on maxillary sinus floor bone augmentation as a preliminary pilot study. 5 patients that required sinus floor augmentation to facilitate the placement of dental implants participated in this study. The primary outcome was a safety verification of triple-concentrated FD-PRP (x3 FD-PRP) and there were no adverse events related to the transplantation of FD-PRP.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

1. All patients are required to be nonsmokers. 2. Patients who have systemic disease, malignances, chronic infections, immune system abnormalities, septicemia, syphilis, HBV, HCV, HTLV-1, HIV, pregnancy, dementia. 3. Patients who have disorder of blood coagulation. 4. Patients who have hepatitis function disorders, metabolic bone disease or skeletal dysplasia. 5. Patients who needs the legal representative.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety (including the adverse events)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath